Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement levels in acute infectious hepatitis and serum hepatitis.

Literature DB >> 4624985

Complement levels in acute infectious hepatitis and serum hepatitis.

J C Kosmidis, L K Leader-Williams.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1972 PMID： 4624985 PMCID： PMC1553673

Source DB: PubMed Journal: Clin Exp Immunol ISSN： 0009-9104 Impact factor: 4.330

× No keyword cloud information.

17 in total

1. Serum complement levels in systemic lupus erythematosus and other diseases.

Authors: G L ASHERSON
Journal: Australas Ann Med Date: 1960-02

2. Serum complement in hepatobiliary diseases.

Authors: E E MANDEL; K LANGE
Journal: Proc Soc Exp Biol Med Date: 1955-12

3. E. Complement. The immunochemistry of complement.

Authors: P J Lachmann
Journal: Proc R Soc Lond B Biol Sci Date: 1969-07-01

Review 4. Review: antigens and viruses in acute hepatitis.

Authors: A J Zuckerman; P E Taylor; R G Bird
Journal: Clin Exp Immunol Date: 1970-10 Impact factor: 4.330

5. Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors: G Mancini; A O Carbonara; J F Heremans
Journal: Immunochemistry Date: 1965-09

6. [Serum complement in various acute and chronic liver diseases].

Authors: R Farini; P F Gambari; U Fagiolo; A Castellani; A Rizzo; G Erle; R Naccarato
Journal: G Clin Med Date: 1970-05

7. Faecal S.H. (Australia) antigen in acute hepatitis.

Authors: P J Grob; H Jemelka
Journal: Lancet Date: 1971-01-30 Impact factor: 79.321

8. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

Authors: E Alpert; K J Isselbacher; P H Schur
Journal: N Engl J Med Date: 1971-07-22 Impact factor: 91.245

9. A complement-fixation test for measuring Australia antigen and antibody.

Authors: R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal: J Infect Dis Date: 1969-09 Impact factor: 5.226

10. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors: F J Dudley; R A Fox; S Sherlock
Journal: Lancet Date: 1971-07-03 Impact factor: 79.321

11 in total

1. Acute hepatitis: significance of changes in complement components.

Authors: J A Charlesworth; S Lawrence; P A Worsdall; L P Roy; C R Boughton
Journal: Clin Exp Immunol Date: 1977-06 Impact factor: 4.330

2. Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases.

Authors: T Michalak
Journal: Am J Pathol Date: 1978-03 Impact factor: 4.307

Complement levels in acute infectious hepatitis and serum hepatitis.

1. Serum complement levels in systemic lupus erythematosus and other diseases.

2. Serum complement in hepatobiliary diseases.

3. E. Complement. The immunochemistry of complement.

Review 4. Review: antigens and viruses in acute hepatitis.

5. Immunochemical quantitation of antigens by single radial immunodiffusion.

6. [Serum complement in various acute and chronic liver diseases].

7. Faecal S.H. (Australia) antigen in acute hepatitis.

8. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies.

9. A complement-fixation test for measuring Australia antigen and antibody.

10. Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

1. Acute hepatitis: significance of changes in complement components.

2. Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. A study of seven necropsy cases.

Review 3. Problems of bacterial infection in patients with liver disease.

4. Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Review 5. Immune complexes in human diseases: a review.

6. Immune complexes in acute and chronic liver disease.

7. HBsAg immune complexes in the course of infection with hepatitis B virus.

8. Immune reactions in acute viral hepatitis.

9. Serum complement in chronic liver disease.

10. Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.